Directly addressing the international demand for batch-to-batch chemical equivalence, validated chromatographic assays, and end-to-end regulatory compliance from pilot extraction to commercial finished dosage forms.
Moving beyond crude dry-matter extraction ratios toward molecularly verified, clinically validated, and chemically fingerprinted botanical potency for international regulated markets.
Global pharmaceutical entities and Tier-1 nutraceutical manufacturers no longer accept vague 'extract ratios' (such as 10:1 or 20:1). Sourcing requirements mandate rigorous quantification of primary and secondary metabolites, standardized active marker density, known EC50/IC50 pharmacological action profiles, and zero synthetic adulteration.
Learn more about active assay targets →Botanicals natively suffer from variance caused by soil composition, altitude, solar exposure, and harvest periods. China potency suppliers must resolve these batch discrepancies via centralized origin screening, chromatographic fingerprint alignment, optimized resin purification, and precise thermal control during extraction and crystallization.
Review seasonal potency variance data →Sourcing from China demands multi-jurisdictional alignment with USP, Ph. Eur., ChP, and Japanese Pharmacopoeia. MedGence acts as both an analytical gatekeeper and industrial CDMO, providing full validation protocols, residual solvent monitoring (ICH Q3C), elemental impurity controls (ICH Q3D), and cGMP audit trails.
Explore global compliance frameworks →MedGence (Yineng Pharma) provides fully integrated preclinical research, analytical method validation, and commercial CDMO manufacturing under non-disclosure governance.
Plants contain intricate arrays of alkaloids, polyphenols, polysaccharides, and saponins. Utilizing high-throughput screening and mass-spectrometric profiling, we isolate target bioactive molecules responsible for designated physiological endpoints while discarding inactive ballast matter.
View Screening Protocols →Active compound densities fluctuate sharply based on geographic longitude, latitude, terroir, and harvest timing. Our geobotanical studies systematically quantify seasonal and regional potency curves to secure raw materials with peak natural yield.
Examine Terroir Analytics →Robust quality requires validated analytical chemistry. We construct robust test procedures using High-Performance Thin-Layer Chromatography (HPTLC), reversed-phase HPLC, GC-MS, and multi-wavelength chromatographic fingerprinting, establishing definitive marker assays.
Method Development Details →Industrial profitability relies on extraction yield and purity kinetics. We optimize counter-current extraction, macroporous adsorption resin columns, membrane separation, and spray or vacuum freeze-drying to safeguard delicate thermolabile structures.
Explore Extraction Scaling →Transforming potent extracts into stable, bioavailable dosage forms frequently introduces excipient interaction or bioavailability hurdles. Our pharmaceutical formulators eliminate degradation, oxidation, and precipitation in complex mixtures.
Dosage Engineering Tech →Potency must be counterbalanced by verified toxicological safety. We execute acute toxicity (oral and dermal LD50), sub-chronic 90-day repeat dose regimens, Ames bacterial reverse mutation tests, and in vitro micronucleus genotoxicity assays.
Toxicological Safety Standards →Our bioassay suites utilize human primary cell cultures and immortalized cell lines to evaluate cytokine suppression (TNF-α, IL-6), antioxidant capacity, metabolic enzyme modulation, and pathway receptor binding at early discovery stages.
Cellular Assay Capabilities →Validating systemic efficacy through rodent disease models for metabolic syndrome, neurodegenerative stress, chronic inflammation, and immune dysfunction. In vivo pharmacokinetic (PK/PD) studies map biological absorption, distribution, metabolism, and excretion.
Animal Study Models →Partnering with Tier-3A TCM hospitals and clinical research centers across China, we oversee protocol design, GCP monitoring, double-blind randomized placebo-controlled trials, and statistical endpoints to satisfy NDA and health-claim requirements.
Clinical Trial Packages →Extracting the pharmacological rationale from historic botanical formulas, our scientists decipher multi-component synergy. We have systematically modernized 83 classical formulas, isolating active fractions while validating clinical efficacy against modern diagnostic biomarkers.
Modern Formulation Science →Scalable manufacturing of purified phytoconstituents as high-viscosity pastes, crystallization powders, concentrated liquids, and volatile essential oils. Cleanrooms operate under cGMP conditions with strict physical identity controls.
Bulk Raw Material Specs →Full-chain commercial manufacturing covering oral liquid vials, enteric hard gelatin capsules, vegan pullulan capsules, softgels, micro-tablets, and functional effervescent granules—packaged ready for pharmaceutical or supplement market entry.
Finished Dosage Catalogs →Over 14+ years of specialized execution serving public hospitals, national research academies, and multinational pharmaceutical enterprises.
How algorithmic molecular docking, continuous flow purification, and clean-tech extraction will define the next generation of botanical potency suppliers.
Integrating high-performance computing to simulate interactions between botanical small-molecule libraries and target physiological receptors prior to wet-lab screening.
Transitioning from traditional multi-stage batch vessels to automated continuous-flow liquid-liquid chromatography, slashing solvent volumes by 65% while increasing active yield.
Eliminating petroleum-derived hydrocarbons through dynamic supercritical fluid extraction combined with food-grade bio-ethanol co-solvents to satisfy global ESG criteria.
Pairing wild-harvested and agricultural plant precursors with enzyme-catalyzed biotransformation to boost micro-fraction potency to pharmaceutical purity standards.
Navigating import tariffs, botanical drug dossiers, and regional contaminants mandates without delaying commercial product release.
For North American distributors and clinical sponsors, we assemble complete Drug Master Files (Type IV / V DMFs) and New Dietary Ingredient (NDI) safety filings, complete with 90-day subchronic toxicity data, full composition specs, and accelerated stability data (ICH Q1A).
Meeting European Medicines Agency (EMA) and EFSA guidance through strict monitoring of polycyclic aromatic hydrocarbons (PAHs), heavy metals (Pb, Cd, Hg, As), ethylene oxide residues, and pyrrolizidine alkaloid (PA) contamination down to sub-ppb thresholds.
Operating entirely on a fee-for-service research model, all proprietary botanical extraction parameters, crystallization protocols, excipient binders, and clinical insights remain 100% the unencumbered intellectual property of the commissioning partner.
Our botanical potency validation and contract manufacturing platforms power major clinical hospital preparations and commercial pharmaceutical manufacturers.
Tongrentang Group
CR Sanjiu
Sunflower Pharma
Livzon Pharma
Dihon Pharma
Golden Throat
Yangtzi River Pharma
Beihai Gofar
Humanwell Healthcare
SCIMYTH Pharma
Shandong Hanfang
Luoxin Pharma
Zhongsheng Pharma
Brilliance & Abundance
Apeloa Pharma
Heng Chang Pharma
Baotou TCM
Shuguang Hospital
Targeting critical parameters evaluated by R&D Directors, Chief Procurement Officers, and Regulatory Affairs Executives.
Access our standardized phytochemical pipelines or initiate custom contract synthesis, process optimization, and industrial scale production.
Submit target indications, required active compound purity, preferred raw botanical origins, or analytical assay specifications. Our scientific team responds with a detailed scope of work, chromatographic validation plan, and commercial timeline within 2 business days.
